AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1301124 — intervention group
Group type: EXPERIMENTAL
Intervention: Dartmouth COOP Charts used by 29 Chart physicians
Number of subjects: 56
Study 1301124 — intervention group
Group type: COMPARATOR
Intervention: No measure of health status used by 27 control clinicians
Number of subjects: 56
Study 4006345 — intervention group
Group type: EXPERIMENTAL
Intervention: Static contraction (one-arm handgrip and two-leg extension at 30% of maximal voluntary contraction for 3 min)
Number of subjects: 22
Study 29790478 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting Full-cycle Ratio (RFR)
Number of subjects: 651
Study 29790478 — intervention group
Group type: COMPARATOR
Intervention: instantaneous wave‐free ratio (iFR)
Number of subjects: 651
Study 27612562 — intervention group
Group type: EXPERIMENTAL
Intervention: SCOHP (Stroke and Carer Optimal Health Program)
Number of subjects: 168
Study 27612562 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 168
Study 23316080 — intervention group
Group type: EXPERIMENTAL
Intervention: adalimumab+MTX
Number of subjects: 334
Study 23316080 — intervention group
Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 334
Study 22334807 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilevel positive airway pressure with pressure release technology (Bi‐Flex)
Number of subjects: 56
Study 22334807 — intervention group
Group type: COMPARATOR
Intervention: Standard continuous positive airway pressure (CPAP) therapy
Number of subjects: 56
Study 21211331 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective ECG-gated 320-detector CTCA
Number of subjects: 480
Study 21211331 — intervention group
Group type: COMPARATOR
Intervention: Retrospective ECG-gated 320-detector CTCA
Number of subjects: 480
Study 19014164 — intervention group
Group type: EXPERIMENTAL
Intervention: New uncovering technique
Number of subjects: 33
Study 19014164 — intervention group
Group type: COMPARATOR
Intervention: Conventional uncovering technique
Number of subjects: 33
Study 16169338 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 50
Study 16169338 — intervention group
Group type: COMPARATOR
Intervention: Femoral access
Number of subjects: 50
Study 16169338 — intervention group
Group type: EXPERIMENTAL
Intervention: Both access sites
Number of subjects: 50
Study 14567091 — intervention group
Group type: EXPERIMENTAL
Intervention: Margarine with plant sterol esters (30 g/d with 8 g/100 g of product)
Number of subjects: 42
Study 14567091 — intervention group
Group type: COMPARATOR
Intervention: Butter (30 g/d)
Number of subjects: 42
Study 10636618 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH)
Number of subjects: 34
Study 10636618 — intervention group
Group type: COMPARATOR
Intervention: Control (no ANH)
Number of subjects: 34
Study 8938498 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital admission on the day of surgery, discharge the day after; two consultations at the outpatient department; one visit by the community nurse before surgery, two visits after.
Number of subjects: 120
Study 8938498 — intervention group
Group type: EXPERIMENTAL
Intervention: Mostly as for 2. with two GP visits replacing the two consultations at the outpatient department.
Number of subjects: 120
Study 8938498 — intervention group
Group type: COMPARATOR
Intervention: Traditional hospital stay.
Number of subjects: 120
Study 1390962 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment group (psychological treatment package including relaxation training, electromyogram, and thermal biofeedback)
Number of subjects: 8
Study 1390962 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment group
Number of subjects: 8
Study 1390962 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment group
Number of subjects: 8
Study 1390962 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed treatment)
Number of subjects: 8
Study 1390962 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 8
Study 3883902 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical minoxidil therapy (1.0 mL applied twice a day)
Number of subjects: 56
Study 3883902 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical minoxidil therapy
Number of subjects: 56
Study 31474546 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim 10 μg/kg once weekly
Number of subjects: 35
Study 31474546 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim 6 μg/kg once weekly
Number of subjects: 35
Study 31474546 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim 3 μg/kg once weekly
Number of subjects: 35
Study 31474546 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim 1 μg/kg once weekly
Number of subjects: 35
Study 31474546 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim during weeks 46-53
Number of subjects: 35
Study 31474546 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim at 2 and 3 years
Number of subjects: 35
Study 31474546 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-related adverse events
Number of subjects: 35
Study 31474546 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events of grade 3 or higher
Number of subjects: 35
Study 31474546 — intervention group
Group type: EXPERIMENTAL
Intervention: Death during treatment
Number of subjects: 35
Study 29595303 — intervention group
Group type: EXPERIMENTAL
Intervention: Prequestion group
Number of subjects: 0
Study 29595303 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 29595303 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 0
Study 26449934 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-educational group intervention delivered in three sessions by health professionals (physician, nurse, social worker/priest)
Number of subjects: 119
Study 26449934 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-educational group intervention
Number of subjects: 119
Study 26449934 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 119
Study 25518530 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste (CH)
Number of subjects: 51
Study 25518530 — intervention group
Group type: EXPERIMENTAL
Intervention: Gutta-percha points containing calcium hydroxide (CH-GP)
Number of subjects: 51
Study 25518530 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX-GP)
Number of subjects: 51
Study 22441892 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily for 6 months
Number of subjects: 77
Study 22441892 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg daily for 6 months
Number of subjects: 77
Study 22441892 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal cholesterol levels)
Number of subjects: 77
Study 20520776 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% ethanol lock for 15 minutes per day
Number of subjects: 376
Study 20520776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376
Study 20520776 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% ethanol lock
Number of subjects: 376
Study 17655668 — intervention group
Group type: EXPERIMENTAL
Intervention: CTI ablation (Group CTI+)
Number of subjects: 188
Study 17655668 — intervention group
Group type: COMPARATOR
Intervention: LA ablation alone (Group CTI-)
Number of subjects: 188
Study 11407427 — intervention group
Group type: EXPERIMENTAL
Intervention: Early bilinguals
Number of subjects: 2
Study 11407427 — intervention group
Group type: EXPERIMENTAL
Intervention: Late bilinguals
Number of subjects: 2
Study 9686470 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal color Doppler ultrasonography
Number of subjects: 140
Study 8293640 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)
Number of subjects: 58
Study 8293640 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 58
Study 8293640 — intervention group
Group type: COMPARATOR
Intervention: MRI
Number of subjects: 58
Study 8293640 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 58
Study 2951871 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (Adalat; Bayer‐Miles)
Number of subjects: 0
Study 29340826 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic surgery (SPLS)
Number of subjects: 180
Study 26135473 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic-on-metal (CoM)
Number of subjects: 390
Study 26135473 — intervention group
Group type: COMPARATOR
Intervention: Metal-on-metal (MoM)
Number of subjects: 390
Study 25428342 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangquan Recipe (KQR)
Number of subjects: 106
Study 25428342 — intervention group
Group type: COMPARATOR
Intervention: Cernilton
Number of subjects: 106
Study 24334318 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrinsic motivation group
Number of subjects: 42
Study 24334318 — intervention group
Group type: COMPARATOR
Intervention: Externally regulated motivation group
Number of subjects: 42
Study 24334318 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study 20642376 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma management intervention
Number of subjects: 90
Study 18701641 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone
Number of subjects: 0
Study 18701641 — intervention group
Group type: EXPERIMENTAL
Intervention: Iridium
Number of subjects: 0
Study 18701641 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17067102 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital thrombolysis
Number of subjects: 800
Study 17067102 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 800
Study 14505143 — intervention group
Group type: EXPERIMENTAL
Intervention: Japan's share of articles in gastroenterology and hepatology
Number of subjects: 0
Study 14505143 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall articles from Japan
Number of subjects: 0
Study 14505143 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs) from Japan
Number of subjects: 0
Study 11728269 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium Heparin (CH) - 12,500 IU subcutaneous daily for 3 months, followed by 325 mg ASA daily for 3 months
Number of subjects: 90
Study 11728269 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic Acid (ASA) - 325 mg/day for 6 months
Number of subjects: 90
Study 11728269 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study 8790079 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin therapy
Number of subjects: 64
Study 8790079 — intervention group
Group type: EXPERIMENTAL
Intervention: Ping-ponging elicitation method
Number of subjects: 64
Study 8790079 — intervention group
Group type: COMPARATOR
Intervention: Starting at the known efficacy method
Number of subjects: 64
Study 1506947 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cost education and feedback intervention (brief orientation, pamphlet of cost strategies, detailed interim bills, information about projected length of stay and usual hospital reimbursement)
Number of subjects: 1432
Study 1506947 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cost education and feedback intervention
Number of subjects: 1432
Study 1506947 — intervention group
Group type: COMPARATOR
Intervention: Control services
Number of subjects: 1432
Study 31955002 — intervention group
Group type: EXPERIMENTAL
Intervention: CDDP + S-1
Number of subjects: 102
Study 31955002 — intervention group
Group type: COMPARATOR
Intervention: CDDP + PEM
Number of subjects: 102
Study 30980253 — intervention group
Group type: EXPERIMENTAL
Intervention: Rare disaster information
Number of subjects: 242
Study 30980253 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 242
Study 29138535 — intervention group
Group type: EXPERIMENTAL
Intervention: Eporon® (4,000 IU)
Number of subjects: 42
Study 29138535 — intervention group
Group type: COMPARATOR
Intervention: Eprex® (4,000 IU)
Number of subjects: 42
Study 29138535 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 42
Study 24831039 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based communication for support
Number of subjects: 30
Study 23835185 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised physiotherapy‐directed occupational health programme (six 30‐minute sessions over 5 months)
Number of subjects: 69
Study 23835185 — intervention group
Group type: COMPARATOR
Intervention: Control group with pseudo-intervention of one oral education session
Number of subjects: 69
Study 23835185 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised physiotherapy‐directed occupational health programme
Number of subjects: 69
Study 23835185 — intervention group
Group type: COMPARATOR
Intervention: Control group with pseudo-intervention
Number of subjects: 69
Study 23054196 — intervention group
Group type: EXPERIMENTAL
Intervention: VHS: single implementation intention
Number of subjects: 69
Study 23054196 — intervention group
Group type: EXPERIMENTAL
Intervention: VHS: multiple implementation intentions
Number of subjects: 69
Study 23054196 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-generated implementation intention
Number of subjects: 69
Study 23054196 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 69
Study 20104986 — intervention group
Group type: EXPERIMENTAL
Intervention: High intake of vegetables
Number of subjects: 114
Study 20104986 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit consumption
Number of subjects: 114
Study 20104986 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish consumption
Number of subjects: 114
Study 20104986 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of foods fried in vegetable oil
Number of subjects: 114
Study 17875340 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin beta 150 IU/kg three times weekly until 4 weeks after last chemotherapy cycle
Number of subjects: 102
Study 17875340 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin beta
Number of subjects: 102
Study 15986591 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF as preoperative second-line chemotherapy
Number of subjects: 13
Study 15986591 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel or docetaxel as second-line treatment
Number of subjects: 13
Study 12454562 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg/day)
Number of subjects: 11
Study 12454562 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine (9 mg/day)
Number of subjects: 11
Study 12454562 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined effects of donepezil and rivastigmine
Number of subjects: 11
Study 10554542 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium treatment for 19 days in addition to a complete in-patient rehabilitation cure based on a behavioural approach
Number of subjects: 53
Study 10554542 — intervention group
Group type: COMPARATOR
Intervention: Control group (41 patients)
Number of subjects: 53
Study 8974615 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting GnRH agonist (effective for 24 hours)
Number of subjects: 160
Study 8974615 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting GnRH analog
Number of subjects: 160
Study 1718252 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser treatment for classic CNV
Number of subjects: 0
Study 1718252 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser treatment for subfoveal recurrent CNV
Number of subjects: 0
Study 6352267 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg oral)
Number of subjects: 46
Study 6352267 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg three times daily)
Number of subjects: 46
Study 6352267 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 46
Study 6352267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 30703644 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-month DAPT group (abbreviated antiplatelet regimen)
Number of subjects: 4300
Study 30703644 — intervention group
Group type: COMPARATOR
Intervention: Standard antiplatelet regimen (at least 5 months DAPT)
Number of subjects: 4300
Study 26990786 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cell phone intervention
Number of subjects: 195
Study 25650816 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivor‐Lewis esophagectomy
Number of subjects: 300
Study 25650816 — intervention group
Group type: COMPARATOR
Intervention: Sweet esophagectomy
Number of subjects: 300
Study 24337476 — intervention group
Group type: EXPERIMENTAL
Intervention: Stand up comedy training
Number of subjects: 36
Study 24337476 — intervention group
Group type: COMPARATOR
Intervention: Discussing comedy videos (active control)
Number of subjects: 36
Study 24337476 — intervention group
Group type: COMPARATOR
Intervention: No humour-related intervention (passive control)
Number of subjects: 36
Study 22855868 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbecue rotation
Number of subjects: 170
Study 22855868 — intervention group
Group type: EXPERIMENTAL
Intervention: Gufoni maneuver
Number of subjects: 170
Study 22855868 — intervention group
Group type: COMPARATOR
Intervention: Sham maneuver
Number of subjects: 170
Study 19947792 — intervention group
Group type: EXPERIMENTAL
Intervention: Fagerström Test for Nicotine Dependence
Number of subjects: 608
Study 19947792 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Dependence Syndrome Scale
Number of subjects: 608
Study 19947792 — intervention group
Group type: EXPERIMENTAL
Intervention: Wisconsin Inventory of Smoking Dependence Motives
Number of subjects: 608
Study 19947792 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine dependence measures' scales and items
Number of subjects: 608
Study 17207304 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablet (FBT)
Number of subjects: 105
Study 17207304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 15754485 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 0
Study 15754485 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition
Number of subjects: 0
Study 11409115 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (Enbrel)
Number of subjects: 628
Study 9926571 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (100 mg/100 ml dose)
Number of subjects: 40
Study 9926571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 7865642 — intervention group
Group type: EXPERIMENTAL
Intervention: Smooth muscle relaxants (myorelaxants)
Number of subjects: 26
Study 7865642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 2838221 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniroid ointment
Number of subjects: 89
Study 2838221 — intervention group
Group type: EXPERIMENTAL
Intervention: Proctosedyl ointment
Number of subjects: 89
Study 2838221 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniroid suppository
Number of subjects: 89
Study 2838221 — intervention group
Group type: EXPERIMENTAL
Intervention: Proctosedyl suppository
Number of subjects: 89
Study 2838221 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ointment and suppository formulations
Number of subjects: 89
Study 2838221 — intervention group
Group type: EXPERIMENTAL
Intervention: All four preparations
Number of subjects: 89
Study 31995570 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily lipid‐based micronutrient supplement commencing ≥3 months prior to conception (Arm 1)
Number of subjects: 972
Study 31995570 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily lipid‐based micronutrient supplement in the 1st trimester (Arm 2)
Number of subjects: 972
Study 31995570 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplement, Arm 3)
Number of subjects: 972
Study 29446523 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy with dapagliflozin 10 mg/d plus saxagliptin 5 mg/d plus metformin
Number of subjects: 0
Study 29446523 — intervention group
Group type: COMPARATOR
Intervention: Dual therapy with dapagliflozin or saxagliptin plus metformin
Number of subjects: 0
Study 29446523 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential add-on therapy with dapagliflozin 10 mg/d or saxagliptin 5 mg/d
Number of subjects: 0
Study 29446523 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant add-on therapy with dapagliflozin 10 mg/d plus saxagliptin 5 mg/d
Number of subjects: 0
Study 29446523 — intervention group
Group type: EXPERIMENTAL
Intervention: All analysis groups
Number of subjects: 0
Study 28449699 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-length shoe-stiffening insert(s) plus rehabilitation therapy
Number of subjects: 90
Study 28449699 — intervention group
Group type: COMPARATOR
Intervention: Sham shoe insert(s) plus rehabilitation therapy
Number of subjects: 90
Study 26134993 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin and protamine dosing with Hepcon HMS Plus device
Number of subjects: 60
Study 26134993 — intervention group
Group type: COMPARATOR
Intervention: Standard weight and activated clotting time (ACT) based dosing
Number of subjects: 60
Study 22834636 — intervention group
Group type: EXPERIMENTAL
Intervention: 15(R/S)-methyl-lipoxin A(4) cream
Number of subjects: 60
Study 22834636 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate (Eloson)
Number of subjects: 60
Study 22834636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 21054484 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of 0.5 mL of hypertonic saline
Number of subjects: 11
Study 21054484 — intervention group
Group type: COMPARATOR
Intervention: Injection of 0.5 mL of isotonic saline
Number of subjects: 11
Study 18298709 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lorazepam 1 mg
Number of subjects: 138
Study 18298709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 16376489 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 100 mg/m2 (D1, D22, D43); 5FU, continuous infusion (D1‐‐>D5), 750 mg/m2/day cycle 1; 430 mg/m2/day cycles 2 and 3
Number of subjects: 163
Study 16376489 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (arm A)
Number of subjects: 163
Study 16376489 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin/5-FU chemotherapy (arm B)
Number of subjects: 163